KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Change in Accured Expenses (2016 - 2025)

CareDx's Change in Accured Expenses history spans 13 years, with the latest figure at -$8.8 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 205.01% year-over-year to -$8.8 million; the TTM value through Dec 2025 reached -$3.3 million, down 117.72%, while the annual FY2025 figure was -$3.3 million, 117.72% down from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$8.8 million at CareDx, down from -$2000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $22.2 million in Q2 2022 and bottomed at -$14.6 million in Q1 2022.
  • The 5-year median for Change in Accured Expenses is $2.7 million (2023), against an average of $2.0 million.
  • The largest annual shift saw Change in Accured Expenses skyrocketed 2227.27% in 2021 before it tumbled 205.01% in 2025.
  • A 5-year view of Change in Accured Expenses shows it stood at $3.0 million in 2021, then skyrocketed by 61.39% to $4.8 million in 2022, then plummeted by 38.27% to $3.0 million in 2023, then soared by 181.78% to $8.4 million in 2024, then crashed by 205.01% to -$8.8 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Change in Accured Expenses are -$8.8 million (Q4 2025), -$2000.0 (Q3 2025), and -$764000.0 (Q2 2025).